AcelleRX Therapeutics Preparing For Phase 1 Clinical Trial Of Chronic Heart Failure Treatment

Armen Hareyan's picture

Chronic Heart Failure Treatment


AcelleRX will use the funds to prepare for a Phase I clinical trial of its Stromal Derived Factor-1 (SDF-1) as a treatment for chronic heart failure, a condition affecting 550,000 new patients each year.

Jump Start, Inc., North Coast Angel Fund, and X-Gen

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.